Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/16/1999WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999WO1999063970A1 Delavirdine tablet formulation
12/16/1999WO1999063967A1 Enhanced intra vaginal devices
12/16/1999WO1999063947A2 Method of hiv and hpv prophylaxis
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063943A2 Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
12/16/1999WO1999063942A2 Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated 'agelagalastatin'
12/16/1999WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999WO1999063938A2 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
12/16/1999WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063934A2 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063931A2 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999WO1999063928A2 Pharmaceutical product for hemophilia and asthmatic bronchitis treatment
12/16/1999WO1999063841A1 Compositions comprising phytosterol and/or phytostanol having enhanced solubility and dispersability
12/16/1999WO1999063816A1 Method and composition for the treatment of epidermal irritations and infections
12/16/1999WO1999056736A3 Apoptosis-inducing compounds
12/16/1999WO1999055686A3 Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds
12/16/1999WO1999054280B1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
12/16/1999WO1999052546A3 A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
12/16/1999WO1999050268A3 Substituted indolealkanoic acids
12/16/1999WO1999048461A3 Substituted aromatic compounds for treatment of antibiotic resistant infections
12/16/1999WO1999043651A3 Inhibitors of phospholipase enzymes
12/16/1999WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto
12/16/1999DE19826499A1 Use of lactone, thiolactone and/or dithiolactone derivatives
12/16/1999DE19826365A1 Verwendung von Benzomorphanderivaten als Analgetikum Use of Benzomorphanderivaten as an analgesic
12/16/1999DE19826213A1 Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New antiestrogens, processes for their preparation and their pharmaceutical use
12/16/1999DE19825856A1 New topical formulation which includes active agent as liquid lipid nanoparticles in an oil-in-water emulsion
12/16/1999DE19825804A1 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung 1,4-benzothiazepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
12/16/1999DE19825746A1 Kombination von Selen-haltigen Verbindungen mit Zytostatika Combination of selenium-containing compounds with cytotoxic drugs
12/16/1999CA2768882A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768841A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768828A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768773A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768682A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2706350A1 Method of hiv and hpv prophylaxis
12/16/1999CA2343824A1 Method of hiv and hpv prophylaxis
12/16/1999CA2337822A1 Inhibitors of the anandamide transporter as analgesic agents
12/16/1999CA2335339A1 .beta.-carboline compounds
12/16/1999CA2334990A1 Novel use of hiv protease inhibiting compounds
12/16/1999CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999CA2334970A1 Quinazolinone inhibitors of cgmp phosphodiesterase
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334814A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
12/16/1999CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999CA2334798A1 1,5-benzodiazepine derivatives
12/16/1999CA2334788A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
12/16/1999CA2334780A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
12/16/1999CA2334760A1 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems
12/16/1999CA2334671A1 Pyrido¬2,3-b|indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999CA2334652A1 Protease inhibitors
12/16/1999CA2334625A1 Extracts of hypericum perforatum and formulations containing them
12/16/1999CA2334611A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999CA2334609A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999CA2334607A1 Use of a nk-1 receptor antagonist for treating sexual dysfunctions
12/16/1999CA2334606A1 Use of an nk-1 receptor antagonist for treating cognitive disorders
12/16/1999CA2334580A1 Use of a nk-1 receptor antagonist for treating bipolar disorders
12/16/1999CA2334558A1 .alpha.-(1-piperazinyl)acetamido arenecarboxylic acid derivatives as antidiabetic agents
12/16/1999CA2334551A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999CA2334545A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators
12/16/1999CA2334481A1 Compositions and methods for treatment of cough
12/16/1999CA2334454A1 Quarternary ammonium compounds as anti-tussive agents
12/16/1999CA2334449A1 Compositions comprising phytosterol, phytostanol or mixtures of both having enhanced solubility and dispersability and incorporation thereof into foods, beverages, pharmaceuticals, nutraceuticals and the like
12/16/1999CA2334313A1 Pharmaceutical compositions containing alpha-tocopherylphosphocholine
12/16/1999CA2334296A1 Enhanced intra vaginal devices
12/16/1999CA2334249A1 Therapeutic agents
12/16/1999CA2334116A1 Treatment of diabetes
12/16/1999CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999CA2333551A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/16/1999CA2333550A1 Crystalline efavirenz
12/16/1999CA2333332A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999CA2333331A1 Stabilized transient gene expression
12/16/1999CA2332831A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999CA2332314A1 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
12/16/1999CA2331918A1 Protecting neurons from ischemia
12/16/1999CA2331794A1 Acetylcholine enhancers
12/16/1999CA2331372A1 Tankyrase, a trfi binding protein
12/16/1999CA2330247A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999CA2330211A1 Formulations for electroporation
12/16/1999CA2329160A1 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
12/16/1999CA2321274A1 Novel antiviral compounds
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321191A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999CA2321162A1 Novel antibacterial compounds
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999CA2320241A1 Multivalent macrolide antibiotics
12/16/1999CA2319761A1 Multibinding inhibitors of hmg-coa reductase
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
1 ... 6394 6395 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 ... 7860